Dimensional Fund Advisors
JSPR icon

Dimensional Fund Advisors’s Jasper Therapeutics JSPR Stock Holding History

Dimensional Fund Advisors’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Hold
18,664
– – ﹤0.01% 3211
2025
Q4 		$34.2K Sell
18,664
-20,299
-52% -$40.8K ﹤0.01% 3224
2025
Q3 		$92.7K Sell
38,963
-5,698
-13% -$17.3K ﹤0.01% 3199
2025
Q2 		$248K Hold
44,661
– – ﹤0.01% 3087
2025
Q1 		$192K Buy
44,661
+6,956
+18% +$46.3K ﹤0.01% 3135
2024
Q4 		$806K Buy
37,705
+780
+2% +$16.2K ﹤0.01% 2954
2024
Q3 		$695K Buy
+36,925
New +$735K ﹤0.01% 2976

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Dimensional Fund Advisors's JSPR Position: Q1 2026 in Review

Dimensional Fund Advisors held its Jasper Therapeutics (JSPR) position steady in Q1 2026 at 18,664 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Dimensional Fund Advisors first reported a position in JSPR in Q3 2024 and has held it in 7 quarters since. The position peaked at $806K in Q4 2024. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Dimensional Fund Advisors held 18,664 shares of Jasper Therapeutics worth $16.4K as of Q1 2026.
  • Dimensional Fund Advisors left its Jasper Therapeutics share count unchanged in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3211 holding.
  • Dimensional Fund Advisors first reported a position in Jasper Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Dimensional Fund Advisors's Jasper Therapeutics position peaked at $806K in Q4 2024.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.